Edward Miles, MD
Radiation Oncology · Dubuque, IANPI 1336311349
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,169 of the $1,904 with a category attached, or 61.4%. Varian Medical Systems, Inc. accounts for 72.6% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2019 at $1,382 and has fallen 88.1% since, to $165 in 2025.
Across 24 payments — averaging $79.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Varian Medical Systems, Inc.$1K
- Puma Biotechnology, Inc.$73
- Isoray, Inc$59
- AstraZeneca$43
- Bayer$42
- Novartis$30
- plus $273 from 11 others
What the payments were for
- Travel & lodging$1,16961%
- Food & beverage$73439%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Varian Medical Systems, Inc. | 7 | $1,382 |
| Puma Biotechnology, Inc. | 1 | $73 |
| Isoray, Inc | 1 | $59 |
| AstraZeneca | 1 | $43 |
| Bayer | 2 | $42 |
| Novartis | 1 | $30 |
| Genentech USA, Inc. | 1 | $29 |
| Lilly USA, LLC | 1 | $29 |
| Syndax Pharmaceuticals, Inc. | 1 | $29 |
| Daiichi Sankyo Inc. | 1 | $25 |
| Merck | 1 | $25 |
| Reflexion Medical, Inc. | 1 | $25 |
| Servier Pharmaceuticals LLC | 1 | $25 |
| Eisai Inc. | 1 | $24 |
| Incyte Corporation | 1 | $23 |
| GSK | 1 | $21 |
| Johnson & Johnson | 1 | $17 |
How this compares
$1,904 in reported general payments places this provider in the 85th percentile of 55 radiation oncology providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 14 | $158 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Dubuque
- Dev PuriDes Moines$32K
- Kristin PlichtaIowa City$6K
- Arshin SheybaniDes Moines$4K
- Robert IsaakDes Moines$3K
- Randy SorumSioux City$3K
- Malgorzata KozakIowa City$2K
- Christine SharisDavenport$2K
- Mark SmithIowa City$2K
- Addison WillettIowa City$1K
- Sarah McAvoyDes Moines$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.